Delivery Order SPE2DB24D1034-SPE2DB24FVYP3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, Corporate Office Division, a major pharmaceutical distributor. The $1,750.22 firm-fixed-price delivery order is for the supply of Lantus Solostar insulin pens, a critical medication used to treat diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,434.46 firm fixed price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens. The award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $7,956.18 for the supply of Lantus Solostar 100 unit/ml 3ml insulin pens. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 26, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $1,295.20 firm fixed-price delivery order is for the supply of Lantus Solostar insulin pens, with a completion date of June 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,322.10 firm-fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens. This award is under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which provides a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The award, which has a ceiling value of $2,078.30, is for the delivery of Lantus Solostar 100 unit/mL 3mL insulin pens. The contract is a firm fixed price delivery order with an ultimate completion date of April 1, 2024. No set-aside designation was used for this award....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $1,477.28 firm-fixed-price delivery order is for the supply of Lantus Solostar insulin delivery devices, which are a critical medical product used to treat diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,022.80, is a firm fixed-price delivery order for Lantus Solostar 100 unit/mL 3mL insulin pens. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of Lantus Solostar insulin pens. The contract has a ceiling value of $1,768.16 and a completion date of May 22, 2024. It is a firm fixed price delivery order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $2,058.44 firm fixed price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens. The contract does not have a set-aside designation. Amerisourcebergen Drug Corporation is the prime contractor on an Indefinite Delivery Contract (IDC)...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB24FVYP3Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,553.75 firm fixed price delivery order is for the supply of Lantus Solostar insulin pens, a specialty medication used to treat diabetes. The award falls under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense military treatment programs and medical facilities worldwide. This IDC, which runs through December 2025, does not have a set-aside designation and was awarded solely to Amerisourcebergen Drug Corp.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 3/14/24 |